Mutagenesis of the supF gene by stereoisomers of 1,2,3,4-diepoxybutane

Chemical Research in Toxicology

Volumn 20, Issue 5, 2007, Pages 790-797

  Min, Young Kim ^a   Tretyakova, Natalia ^b   Wogan, Gerald N ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTADIENE DIEPOXIDE;

ARTICLE; CROSS LINKING; GENE; GENE MUTATION; GENOTOXICITY; MUTAGENESIS; MUTAGENICITY; NONHUMAN; STEREOCHEMISTRY; STEREOISOMERISM; SUPF GENE;

BASE SEQUENCE; DNA ADDUCTS; DNA DAMAGE; DNA MUTATIONAL ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXY COMPOUNDS; GENES, SUPPRESSOR; MOLECULAR SEQUENCE DATA; MUTAGENS; POINT MUTATION; RNA, TRANSFER; STEREOISOMERISM;

EID: 34250789211     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx700003b     Document Type: Article

References (63)

1. Morrow, N. L. (1990) The industrial production and use of 1,3-butadiene. Environ. Health Perspect. 86, 7-8.
2. Pelz, N., Dempster, N. M., and Shore, P. R. (1990) Analysis of low molecular weight hydrocarbons including 1,3-butadiene in engine exhaust gases using an aluminum oxide porous-layer open-tubular fused-silica column. J. Chromatogr. Sci. 28, 230-235.
3. Hecht, S. S. (1999) Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 92, 1194-1210.
4. Malvoisin, E. and Roberfroid, M. (1982) Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica 12, 137-144.
5. Thornton-Manning, J. R., Dahl, A. R., Bechtold, W. E., Griffith, W. C, Jr, and Henderson, R. F. (1995) Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis 16, 1723-1731.
6. Henderson, R. F., Thornton-Manning, J. R., Bechtold, W. E., and Dahl, A. R. (1996) Metabolism of 1,3-butadiene: species differences. Toxicology 113, 17-22.
7. Jelitto, B., Vangala, R. R., and Laib, R. J. (1989) Species differences in DNA damage by butadiene: role of diepoxybutane. Arch. Toxicol., Suppl. 13, 246-249.
8. Henderson, R. F., Barr, E. B., Belinsky, S. A., Benson, J. M., Hahn, F. F., and Menache, M. G. (2000) 1,3-Butadiene: cancer, mutations, and adducts. Part I: Carcinogenicity of 1,2,3,4-diepoxybutane. Res. Rep. Health Eff. Inst. 92, 1-43.
9. Sasiadek, M., Norppa, H., and Sorsa, M. (1991) 1,3-Butadiene and its epoxides induce sister-chromatid in human lymphocytes in vitro. Mutat. Res. 261, 117-121.
10. Kligerman, A. D., DeMarini, D. M., Doerr, C. L., Hanley, N. M., Milholland, V. S., and Tennant, A. H. (1999) Comparison of cytogenetic effects of 3,4-epoxy-1-butene and 1,2:3,4-diepoxybutane in mouse, rat and human lymphocytes following in vitro G0 exposures. Mutat. Res. 439, 13-23.
11. Kligerman, A. D., and Hu, Y. (2006) Some insights into the mode of action of butadiene by examining the genotoxicity of its metabolites. Chem.-Biol. Interact., 166, 132-139.
12. Cochrane, J. E., and Skopek, T. R. (1994) Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutane, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis 15, 713-717.
13. Recio, L., Steen, A., Pluta, L. J., Meyer, K. G., and Sarank, C. J. (2001) Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms. Chem.-Biol. Interact. 135, 325-341.
14. Steen, A. M., Meyer, K. G., and Recio, L. (1997) Characterization of hprt mutations following 1,2-epoxy-3-butene exposure of human TK6 cells. Mutagenesis 12, 359-364.
15. Steen, A. M., Meyer, K. G., and Recio, L. (1997) Analysis of hprt mutations occurring in human TK6 lymphoblastoid cells following exposure to 1,2,3,4-diepoxybutane. Mutagenesis 12, 61-67.
16. Cochrane, J. E., and Skopek, T. R. (1994) Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice. Carcinogenesis 15, 719-723.
17. Meng, Q., Singh, N., Heflich, R. H., Bauer, M. J., and Walker, V. E. (2000) Comparison of the mutations at Hprt exon 3 of T-lymphocytes from B6C3F1 mice and F344 rats exposed by inhalation to 1,3-butadiene or the racemic mixture of 1,2,3,4-diepoxybutane. Mutat. Res. 464, 169-184.
18. Selzer, R. R., and Elfarra, A. A. (1999) In vitro reactions of butadiene monoxide with single- and double-stranded DNA: characterization and quantitation of several purine and pyrimidine adducts. Carcinogenesis 20, 285-292.
19. Selzer, R. R., and Elfarra, A. A. (1996) Synthesis and biochemical characterization of N1-, N2-, and N7-guanosine adducts of butadiene monoxide. Chem. Res. Toxicol. 9, 126-132.
20. Tretyakova, N., Lin, Y., Sangaiah, R., Upton, P. B., and Swenberg, J. A. (1997) Identification and quantitation of DNA adducts from calf thymus DNA exposed to 3,4-epoxy-1-butene. Carcinogenesis 18, 137-147.
21. Neagu, I., Koiviston, P., Neagu, C., Kaltia, S., Kostiainen, P., and Peltonen, K. (1994) Alkylation of purine bases with 3,4-epoxy-1-butene, a reactive metabolite of 1,3-butadiene. IARC Sci. Publ. 419-422.
22. Tretyakova, N., Sangaiah, R., Lin, Y., and Swenberg, J. A. (1997) Synthesis, characterization, and in vitro quantitation of N-7-guanine adducts of diepoxybutane. Chem. Res. Toxicol. 10, 779-785.
23. Lawley, P. D., and Brookes, P. (1967) Interstrand cross-linking of DNA by difunctional alkylating agents. J. Mol. Biol. 25, 143-160.
24. Park, S., and Tretyakova, N. (2004) Structural characterization of the major DNA-DNA cross-link of 1,2,3,4-diepoxybutane. Chem. Res. Toxicol. 17, 129-136.
25. Schmidmaier, R., Oellerich, M., Baumgart, J., Emmerich, B., and Meinhardf, G. (2004) Treosulfan-induced apoptosis in acute myeloid leukemia cells is accompanied by translocation of protein kinase C delta and enhanced by bryostatin-1. Exp. Hematol. (N. Y.) 32, 76-86.
26. Hartley, J. A., ÓHare, C. C., and Baumgart, J. (1999) DNA alkylation and interstrand cross-linking by treosulfan. Br. J. Cancer 79, 264-266.
27. Runowicz, C. D., Fields, A. L., and Goldberg, G. L. (1995) Promising new therapies in the treatment of advanced ovarian cancer. Cancer 76, 2028-2033.
28. Verly, W. G., Brakier, L., and Feit, P. W. (1971) Inactivation of the T7 coliphage by the diepoxybutane stereoisomers. Biochim. Biophys. Acta 228, 400-406.
29. Matagne, R. (1969) Induction of chromosomal aberrations and mutations with isomeric forms of L-threitol-1,4-bismethanesulfonate in plant materials. Mutat. Res. 7, 241-247.
30. Bianchi, A., and Contin, M. (1962) Mutagenic activity of isomeric forms of diepoxybutane in maize. J. Hered. 53, 277-281.
31. Park, S., Anderson, C., Loeber, R., Seetharaman, M., Jones, R., and Tretyakova, N. (2005) Interstrand and intrastrand DNA-DNA cross-linking by 1,2,3,4-diepoxybutane: role of stereochemistry. J. Am. Chem. Soc. 127, 14355-14365.
32. Kim, M. Y., Dong, M., Dedon, P. C., and Wogan, G. N. (2005) Effects of peroxynitrite dose and dose rate on DNA damage and mutation in the supF shuttle vector. Chem. Res. Toxicol. 18, 76-86.
33. Ariza, R. R., Roldan-Arjona, T, Hera, C., and Pueyo, C. (1993) A method for selection of forward mutations in supF gene carried by shuttle-vector plasmids. Carcinogenesis 14, 303-305.
34. Miller, J. H. (1992) A Short Course in Bacterial Genetics: A Laboratory Manual and Handbook for Escherichia coli and Related Bacteria, Cold Spring Harbor, New York.
35. Juedes, M. J., and Wogan, G. N. (1996) Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutat. Res. 349, 51-56.
36. Antsypovich, S., Quirk Dorr, D., Guza, R., Pitts, C., and Tretyakova, N. Structural characterization of exocyclic dA adducts of 1,2,3,4-diepoxybutane. Chem. Res. Toxicol., submitted for publication.
37. Meng, Q., Redetzke, D. L., Hackfeld, L. C., Hodge, R. P., Walker, D. M., and Walker, V. E. (2007) Mutagenicity of stereochemical configurations of 1,2-epoxybutane and 1,2:3,4-diepoxybutane in human cells. Chem.-Biol. Interact., 166, 207-218.
38. Zhang, X. Y., and Elfarra, A. A. (2003) Identification and characterization of a series of nucleoside adducts formed by the reaction of 2′-deoxyguanosine and 1,2,3,4-diepoxybutane under physiological conditions. Chem. Res. Toxicol. 16, 1606-1615.
39. Lee, D. H., Kim, T. H., Lee, S. Y., Kim, H. J., Rhee, S. K., Yoon, B., Pfeifer, G. P., and Lee, C. S. (2002) Mutations induced by 1,3-butadiene metabolites, butadiene diolepoxide, and 1,2,3,4-diepoxybutane at the Hprt locus in CHO-K1 cells. Mol. Cells 14, 411-419.
40. Saranko, C. J., Meyer, K. G., Pluta, L. J., Henderson, R. F., and Recio, L. (2001) Lung-specific mutagenicity and mutational spectrum in B6C3F1 lacI transgenic mice following inhalation exposure to 1,2-epoxybutene. Mutat. Res. 472, 37-49.
41. Saranko, C. J., Pluta, L. J., and Recio, L. (1998) The molecular analysis of lacI mutants from transgenic fibroblasts exposed to the butadiene metabolite, 1,2-epoxybutene. Carcinogenesis 11, 1879-1887.
42. Meng, Q., Walker, D. M., Scott, B. R., Seilkop, S. K., Aden, J. K., and Walker, V. E. (2004) Characterization of Hprt mutations in cDNA and genomic DNA of T-cell mutants from control and 1,3-butadiene-exposed male B6C3F1 mice and F344 rats. Environ. Mol. Mutagen. 43, 75-92.
43. de Meester, C. (1988) Genotoxic properties of 1,3-butadiene. Mutat. Res. 195, 273-281.
44. Melnick, R. L., and Kohn, M. C. (1995) Mechanistic data indicate that 1,3-butadiene is a human carcinogen. Carcinogenesis 16, 157-163.
45. Seaton, M. J., Follansbee, M. H., and Bond, J. A. (1995) Oxidation of 1,2-epoxy-3-butene to 1,2,3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis 16, 2287-2293.
46. Blair, I. A., Oe, T., Kambouris, S., and Chaudhary, A. K. (2000) 1,3-Butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene. Res. Rep. Health Eff. Inst. 92, 151-190.
47. Carmical, J. R., Kowalczyk, A., Zou, Y., Van Houten, B., Nechev, L. V., Harris, C. M., Harris, T. M., and Lloyd, R. S. (2000) Butadiene-induced intrastrand DNA cross-links: a possible role in deletion mutagenesis. J. Biol. Chem. 275, 19482-19489.
48. Adler, I. D., Cochrane, J., Osterman-Golkar, S., Skopek, T. R., Sorsa, M., and Vogel, E. (1995) 1,3-Butadiene working group report. Mutat. Res. 330, 101-114.
49. Carmical, J. R., Nechev, L. V., Harris, C. M., Harris, T. M., and Lloyd, R. S. (2000) Mutagenic potential of adenine N(6) adducts of monoepoxide and diolepoxide derivatives of butadiene. Environ. Mol. Mutagen. 35, 48-56.
50. Carmical, J. R., Zhang, M., Nechev, L. V., Harris, C. M., Harris, T. M., and Lloyd, R. S. (2000) Mutagenic potential of guanine N2 adducts of butadiene mono- and diolepoxide. Chem. Res. Toxicol. 13, 18-25.
51. Millard, J. T., and White, M. M. (1993) Diepoxybutane crosslinks DNA at 5′-GNC sequences. Biochemistry 32, 2120-2124.
52. Tretyakova, N. Y., Sangaiah, R., Yen, T. Y., Gold, A., and Swenberg, J. A. (1997) Adenine adducts with diepoxybutane: isolation and analysis in exposed calf thymus DNA. Chem. Res. Toxicol. 10, 171-1179.
53. Zhang, X. Y., and Elfarra, A. A. (2004) Characterization of the reaction products of 2′-deoxyguanosine and 1,2,3,4-diepoxybutane after acid hydrolysis: formation of novel guanine and pyrimidine adducts. Chem. Res. Toxicol. 17, 521-528.
54. Zhang, X. Y., and Elfarra, A. A. (2005) Reaction of 1,2,3,4-deoxybutane with 2′-deoxyguanosine: initial products and their stabilities and decomposition pattern under physiological conditions. Chem. Res. Toxicol. 18, 1316-1323.
55. 6-deoxyadenosine intrastrand cross-links in mammalian cells. Chem. Res. Toxicol. 15, 1572-1580.
56. Kallama, S., and Hemminki, K. (1986) Stabilities of 7-alkylguanosines and deoxyguanosines formed by phosphoramide mustards and nitrogen mustard. Chem.-Biol. Interact. 57, 85-96.
57. Loeb, L. A. (1985) Apurinic sites as mutagenic intermediates. Cell 40, 483-484.
58. Mudipalli, A., Maccubbin, A. E., Nadadur, S. S., Struck, R. F., and Gurtoo, H. L. (1997) Mutations induced by monofunctional and bifunctional phosphoramide mustards in supF tRNA gene. Mutat. Res. 391, 49-57.
59. Loeb, L. A., and Preston, B. D. (1986) Mutagenesis by apurinic/ apyrimidinic sites. Annu. Rev. Genet. 20, 201-230.
60. Sawyer, G. A., Frederick, E. D., and Millard, J. T. (2004) Flanking sequences modulate diepoxide and mustard cross-linking efficiencies at the 5′-GNC site. Chem. Res. Toxicol. 17, 1057-1063.
61. Millard, J. K., Hanly, T. C., Murphy, K., and Tretyakova, N. (2005) The 5′-GNC site for DNA interstrand cross-linking is conserved for diepoxybutane stereoisomers. Chem. Res. Toxicol. 19, 16-19.
62. Sahasrabudhe, S. R., Luo, X., and Humayan, M. Z. (1991) Specificity of base substitutions induced by the acridine mutagen ICR-191: mispairing by guanine N7 adducts as a mutagenic mechanism. Genetics 129, 981-989.
63. Abu-Shakra, A., McQueen, E. T., and Cunningham, M. L. (2000) Rapid analysis of base-pair substitutions induced by mutagenic drug through their oxygen radical or epoxide derivatives. Mutat. Res. 470, 11-18.